Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GLO2733612
118 Pages
September 2018
Pharmaceuticals

Download Sample Get Discount

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.

Scope of the Report:

This report focuses on the Intravenous (IV) Solutions in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

The worldwide market for Intravenous (IV) Solutions is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

ICU Medical Inc. (U.S.)

B. Braun Melsungen AG (Germany)

Fresenius Kabi AG (Germany)

Baxter (U.S.)

Amanta Healthcare (India)

Terumo Medical Corporation (Tokyo)

Grifols S.A. (Spain)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Market Segment by Applications, can be divided into

Hospital & Clinics

Ambulatory

Home Care

There are 15 Chapters to deeply display the global Intravenous (IV) Solutions market.

Chapter 1, to describe Intravenous (IV) Solutions Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous (IV) Solutions, with sales, revenue, and price of Intravenous (IV) Solutions, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous (IV) Solutions, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous (IV) Solutions market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous (IV) Solutions sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Intravenous (IV) Solutions Introduction

1.2 Market Analysis by Type

1.2.1 Peripheral Parenteral Nutrition

1.2.2 Total Parenteral Nutrition

1.3 Market Analysis by Applications

1.3.1 Hospital & Clinics

1.3.2 Ambulatory

1.3.3 Home Care

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ICU Medical Inc. (U.S.)

2.1.1 Business Overview

2.1.2 Intravenous (IV) Solutions Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 B. Braun Melsungen AG (Germany)

2.2.1 Business Overview

2.2.2 Intravenous (IV) Solutions Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Fresenius Kabi AG (Germany)

2.3.1 Business Overview

2.3.2 Intravenous (IV) Solutions Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Baxter (U.S.)

2.4.1 Business Overview

2.4.2 Intravenous (IV) Solutions Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Amanta Healthcare (India)

2.5.1 Business Overview

2.5.2 Intravenous (IV) Solutions Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Terumo Medical Corporation (Tokyo)

2.6.1 Business Overview

2.6.2 Intravenous (IV) Solutions Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Grifols S.A. (Spain)

2.7.1 Business Overview

2.7.2 Intravenous (IV) Solutions Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Intravenous (IV) Solutions Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Intravenous (IV) Solutions Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Intravenous (IV) Solutions Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Intravenous (IV) Solutions Manufacturer Market Share in 2017

3.3.2 Top 6 Intravenous (IV) Solutions Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Intravenous (IV) Solutions Market Analysis by Regions

4.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Regions

4.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Regions (2013-2018)

4.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Regions (2013-2018)

4.2 North America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.3 Europe Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.5 South America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5 North America Intravenous (IV) Solutions by Countries

5.1 North America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

5.1.1 North America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

5.1.2 North America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

5.2 United States Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5.3 Canada Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

5.4 Mexico Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6 Europe Intravenous (IV) Solutions by Countries

6.1 Europe Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

6.1.1 Europe Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

6.2 Germany Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.3 UK Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.4 France Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.5 Russia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

6.6 Italy Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7 Asia-Pacific Intravenous (IV) Solutions by Countries

7.1 Asia-Pacific Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

7.2 China Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.3 Japan Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.4 Korea Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.5 India Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8 South America Intravenous (IV) Solutions by Countries

8.1 South America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

8.1.1 South America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

8.1.2 South America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8.3 Argentina Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

8.4 Colombia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9 Middle East and Africa Intravenous (IV) Solutions by Countries

9.1 Middle East and Africa Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.3 UAE Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.4 Egypt Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.5 Nigeria Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

9.6 South Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

10 Global Intravenous (IV) Solutions Market Segment by Type

10.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Type (2013-2018)

10.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Type (2013-2018)

10.2 Peripheral Parenteral Nutrition Sales Growth and Price

10.2.1 Global Peripheral Parenteral Nutrition Sales Growth (2013-2018)

10.2.2 Global Peripheral Parenteral Nutrition Price (2013-2018)

10.3 Total Parenteral Nutrition Sales Growth and Price

10.3.1 Global Total Parenteral Nutrition Sales Growth (2013-2018)

10.3.2 Global Total Parenteral Nutrition Price (2013-2018)

11 Global Intravenous (IV) Solutions Market Segment by Application

11.1 Global Intravenous (IV) Solutions Sales Market Share by Application (2013-2018)

11.2 Hospital & Clinics Sales Growth (2013-2018)

11.3 Ambulatory Sales Growth (2013-2018)

11.4 Home Care Sales Growth (2013-2018)

12 Intravenous (IV) Solutions Market Forecast (2018-2023)

12.1 Global Intravenous (IV) Solutions Sales, Revenue and Growth Rate (2018-2023)

12.2 Intravenous (IV) Solutions Market Forecast by Regions (2018-2023)

12.2.1 North America Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.2 Europe Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.3 Asia-Pacific Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.4 South America Intravenous (IV) Solutions Market Forecast (2018-2023)

12.2.5 Middle East and Africa Intravenous (IV) Solutions Market Forecast (2018-2023)

12.3 Intravenous (IV) Solutions Market Forecast by Type (2018-2023)

12.3.1 Global Intravenous (IV) Solutions Sales Forecast by Type (2018-2023)

12.3.2 Global Intravenous (IV) Solutions Market Share Forecast by Type (2018-2023)

12.4 Intravenous (IV) Solutions Market Forecast by Application (2018-2023)

12.4.1 Global Intravenous (IV) Solutions Sales Forecast by Application (2018-2023)

12.4.2 Global Intravenous (IV) Solutions Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Intravenous (IV) Solutions Picture

Table Product Specifications of Intravenous (IV) Solutions

Figure Global Sales Market Share of Intravenous (IV) Solutions by Types in 2017

Table Intravenous (IV) Solutions Types for Major Manufacturers

Figure Peripheral Parenteral Nutrition Picture

Figure Total Parenteral Nutrition Picture

Figure Intravenous (IV) Solutions Sales Market Share by Applications in 2017

Figure Hospital & Clinics Picture

Figure Ambulatory Picture

Figure Home Care Picture

Figure United States Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure France Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure UK Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure China Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure India Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)

Table ICU Medical Inc. (U.S.) Basic Information, Manufacturing Base and Competitors

Table ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Type and Applications

Table ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table B. Braun Melsungen AG (Germany) Basic Information, Manufacturing Base and Competitors

Table B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Type and Applications

Table B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Fresenius Kabi AG (Germany) Basic Information, Manufacturing Base and Competitors

Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Type and Applications

Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Baxter (U.S.) Basic Information, Manufacturing Base and Competitors

Table Baxter (U.S.) Intravenous (IV) Solutions Type and Applications

Table Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amanta Healthcare (India) Basic Information, Manufacturing Base and Competitors

Table Amanta Healthcare (India) Intravenous (IV) Solutions Type and Applications

Table Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Terumo Medical Corporation (Tokyo) Basic Information, Manufacturing Base and Competitors

Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Type and Applications

Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Grifols S.A. (Spain) Basic Information, Manufacturing Base and Competitors

Table Grifols S.A. (Spain) Intravenous (IV) Solutions Type and Applications

Table Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Intravenous (IV) Solutions Sales by Manufacturer (2016-2017)

Figure Global Intravenous (IV) Solutions Sales Market Share by Manufacturer in 2016

Figure Global Intravenous (IV) Solutions Sales Market Share by Manufacturer in 2017

Table Global Intravenous (IV) Solutions Revenue by Manufacturer (2016-2017)

Figure Global Intravenous (IV) Solutions Revenue Market Share by Manufacturer in 2016

Figure Global Intravenous (IV) Solutions Revenue Market Share by Manufacturer in 2017

Figure Top 3 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2017

Figure Global Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Global Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table Global Intravenous (IV) Solutions Sales by Regions (2013-2018)

Table Global Intravenous (IV) Solutions Sales Market Share by Regions (2013-2018)

Table Global Intravenous (IV) Solutions Revenue by Regions (2013-2018)

Figure Global Intravenous (IV) Solutions Revenue Market Share by Regions in 2013

Figure Global Intravenous (IV) Solutions Revenue Market Share by Regions in 2017

Figure North America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Europe Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure South America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure North America Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table North America Intravenous (IV) Solutions Sales by Countries (2013-2018)

Table North America Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)

Figure North America Intravenous (IV) Solutions Sales Market Share by Countries in 2013

Figure North America Intravenous (IV) Solutions Sales Market Share by Countries in 2017

Table North America Intravenous (IV) Solutions Revenue by Countries (2013-2018)

Table North America Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)

Figure North America Intravenous (IV) Solutions Revenue Market Share by Countries in 2013

Figure North America Intravenous (IV) Solutions Revenue Market Share by Countries in 2017

Figure United States Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Canada Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Mexico Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Europe Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table Europe Intravenous (IV) Solutions Sales by Countries (2013-2018)

Table Europe Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)

Table Europe Intravenous (IV) Solutions Revenue by Countries (2013-2018)

Figure Europe Intravenous (IV) Solutions Revenue Market Share by Countries in 2016

Figure Europe Intravenous (IV) Solutions Revenue Market Share by Countries in 2017

Figure Germany Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure UK Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure France Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Russia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Italy Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Intravenous (IV) Solutions Sales by Countries (2013-2018)

Table Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Countries 2017

Table Asia-Pacific Intravenous (IV) Solutions Revenue by Countries (2013-2018)

Figure Asia-Pacific Intravenous (IV) Solutions Revenue Market Share by Countries 2017

Figure China Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Japan Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Korea Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure India Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure South America Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table South America Intravenous (IV) Solutions Sales by Countries (2013-2018)

Table South America Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)

Figure South America Intravenous (IV) Solutions Sales Market Share by Countries in 2017

Table South America Intravenous (IV) Solutions Revenue by Countries (2013-2018)

Table South America Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)

Figure South America Intravenous (IV) Solutions Revenue Market Share by Countries in 2017

Figure Brazil Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Argentina Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Colombia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Intravenous (IV) Solutions Sales by Countries (2013-2018)

Table Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Countries in 2017

Table Middle East and Africa Intravenous (IV) Solutions Revenue by Countries (2013-2018)

Table Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries in 2013

Figure Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries in 2017

Figure Saudi Arabia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure UAE Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Egypt Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure Nigeria Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Figure South Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)

Table Global Intravenous (IV) Solutions Sales by Type (2013-2018)

Table Global Intravenous (IV) Solutions Sales Share by Type (2013-2018)

Table Global Intravenous (IV) Solutions Revenue by Type (2013-2018)

Table Global Intravenous (IV) Solutions Revenue Share by Type (2013-2018)

Figure Global Peripheral Parenteral Nutrition Sales Growth (2013-2018)

Figure Global Peripheral Parenteral Nutrition Price (2013-2018)

Figure Global Total Parenteral Nutrition Sales Growth (2013-2018)

Figure Global Total Parenteral Nutrition Price (2013-2018)

Table Global Intravenous (IV) Solutions Sales by Application (2013-2018)

Table Global Intravenous (IV) Solutions Sales Share by Application (2013-2018)

Figure Global Ambulatory Sales Growth (2013-2018)

Figure Global Home Care Sales Growth (2013-2018)

Figure Global Intravenous (IV) Solutions Sales, Revenue and Growth Rate (2018-2023)

Table Global Intravenous (IV) Solutions Sales Forecast by Regions (2018-2023)

Table Global Intravenous (IV) Solutions Market Share Forecast by Regions (2018-2023)

Figure North America Sales Intravenous (IV) Solutions Market Forecast (2018-2023)

Figure Europe Sales Intravenous (IV) Solutions Market Forecast (2018-2023)

Figure Asia-Pacific Sales Intravenous (IV) Solutions Market Forecast (2018-2023)

Figure South America Sales Intravenous (IV) Solutions Market Forecast (2018-2023)

Figure Middle East and Africa Sales Intravenous (IV) Solutions Market Forecast (2018-2023)

Table Global Intravenous (IV) Solutions Sales Forecast by Type (2018-2023)

Table Global Intravenous (IV) Solutions Market Share Forecast by Type (2018-2023)

Table Global Intravenous (IV) Solutions Sales Forecast by Application (2018-2023)

Table Global Intravenous (IV) Solutions Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Purchase Options

Single User License $3480 Multiple $5220 Corporate $6960

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara